WithdrawnEarly Phase 1NCT04050852
Pulmonary Function Test Changes and Respiratory Muscle Strength Trends in Spinal Muscular Atrophy Patients Receiving Nusinersen Treatments
Studying Autosomal dominant adult-onset proximal spinal muscular atrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- Melodi Pirzada, MDNew York Langone Medical Center
- Intervention
- Nusinersen Treatments(drug)
- Eligibility
- 5-21 years · All sexes
- Timeline
- 2019 – 2021
Study locations (1)
- NYU Langone Health, New York, New York, United States
Collaborators
Winthrop University Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04050852 on ClinicalTrials.govOther trials for Autosomal dominant adult-onset proximal spinal muscular atrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07521930Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)Johns Hopkins University
- ACTIVE NOT RECRUITINGNANCT07547189Effects of Developmental Support for Mothers of Infants With Spinal Muscular AtrophyMedipol University
- RECRUITINGPHASE3NCT07444476A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With RisdiplamBiogen
- RECRUITINGPHASE2NCT07047144A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular AtrophyScholar Rock, Inc.
- RECRUITINGNCT07321990Study of the Reproducibility of the French Version of the Modified SMAFRS ScaleInstitut de Myologie, France
- ACTIVE NOT RECRUITINGNANCT06419322Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA).University of Oxford
- ACTIVE NOT RECRUITINGNANCT06300996Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper LimbMarco Capogrosso
- RECRUITINGNANCT06322654A Head-to-head Study Comparing the Functional Value of Two Models of Robotically Assisted Rehabilitation in SMA (Spinal Muscular Atrophy) PatientsWiktor Dega University Orthopedic and Rehabilitation Hospital
See all trials for Autosomal dominant adult-onset proximal spinal muscular atrophy →